Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.

× No keyword cloud information.

10 in total

Review 1. Genetic polymorphisms in Kawasaki disease.

Authors: Ho-chang Kuo; Wei-chiao Chang
Journal: Acta Pharmacol Sin Date: 2011-09-05 Impact factor: 6.150

Review 2. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors: B S Bochner
Journal: Clin Exp Allergy Date: 2009-03 Impact factor: 5.018

Review 3. Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.

Authors: Ming-Chih Lin
Journal: World J Pediatr Date: 2014-05-07 Impact factor: 2.764

4. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.

Authors: Ho-Chang Kuo; Kuender D Yang; Suh-Hang Hank Juo; Chi-Di Liang; Wei-Chiao Chen; Yu-Shiuan Wang; Chih-Hung Lee; Edward Hsi; Hong-Ren Yu; Peng-Yeong Woon; I-Chun Lin; Chien-Fu Huang; Daw-Yang Hwang; Chiu-Ping Lee; Li-Yan Lin; Wei-Pin Chang; Wei-Chiao Chang
Journal: PLoS One Date: 2011-04-14 Impact factor: 3.240

5. Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment.

Authors: Li-Yan Lin; Tsung-Hsien Yang; Ying-Jui Lin; Hong-Ren Yu; Kuender D Yang; Yi-Chuan Huang; Wei-Chiao Chang; Ho-Chang Kuo
Journal: Pediatr Cardiol Date: 2012-03-25 Impact factor: 1.655

Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.

Review 1. Genetic polymorphisms in Kawasaki disease.

Review 2. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Review 3. Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.

4. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.

5. Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment.

Review 6. Kawasaki Disease and Allergic Diseases.

7. The Impact of Onset Age on Eosinophils in Kawasaki Disease.

8. Elevated Serum Levels of IL-21 in Kawasaki Disease.

9. Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study.

10. Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan.